The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2020

Filed:

Apr. 06, 2016
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Qiongyu Guo, College Park, MD (US);

Jordan J. Green, Nottingham, MD (US);

Randall A. Meyer, Baltimore, MD (US);

Corey J. Bishop, Arlington, MA (US);

Anand Kumar, Baltimore, MD (US);

Gregg L. Semenza, Reisterstown, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 41/00 (2020.01); A61K 47/69 (2017.01); C07K 16/00 (2006.01); A61K 9/16 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01); A61K 31/473 (2006.01); A61K 31/7048 (2006.01); A61K 45/06 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 41/0028 (2013.01); A61K 9/1647 (2013.01); A61K 31/473 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61K 47/6925 (2017.08); A61K 47/6937 (2017.08); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 16/00 (2013.01); B82Y 5/00 (2013.01);
Abstract

The presently disclosed subject matter provides compositions, methods, and kits comprising shape memory particles that can be used for delivering a drug and/or treating a disease or disorder in a patient. Specifically, shape changes in the presently disclosed shape memory particles can be used to control drug delivery spatially and/or temporally in a patient. Also provided are compositions, methods, and kits comprising nanoparticles and hypoxia-inducible factor (HIF) inhibitors with or without chemotherapeutic agents for inhibiting HIF activity in a patient and/or treating a hypoxia-associated disease or disorder.


Find Patent Forward Citations

Loading…